Latest News

• 06 May 2021 – Destiny Pharma Conference Attendance for May 2021
• 04 May 2021 – Equity Development Research Note ‘Destiny Pharma: M3, another gem in the portfolio’
• 04 May 2021 – Posting of Annual Report and Notice of AGM
• 15 Apr 2021 – Investor Presentation – 22 April 2021 at 1400 BST
• 14 Apr 2021 – Results webcast details
• 14 Apr 2021 – Audited results for the year ended 31 December 2020 and positive Phase 2b data announced post year-end
• 29 Mar 2021 – Destiny Pharma to Join Equity Development Webinar
• 29 Mar 2021 – Destiny Pharma Phase 2b results – Analyst and Investor webcast and conference call details – Monday 29th March at 1100 BST
• 29 Mar 2021 – Destiny Pharma Reports Positive Phase 2b Results for XF-73 Nasal Gel
• 16 Mar 2021 – Notice of Full Year Results and Clinical Trial Update